Table of Contents
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Immunoassays
3.3.2 Clinical Chemistry
4 Market Outlook
4.1 Market Definition - Infoholic Research
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.1 Milestones in Molecular Diagnostics
5.2 Basic steps of molecular diagnostics
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing prevalence of Infectious diseases
5.3.1.2 Growing adoption of POC testing
5.3.1.3 Increasing demand for biomarker-based tests
5.3.1.4 High growth of market in emerging countries
5.3.2 Opportunities
5.3.2.1 Growing significance of companion diagnostics
5.3.2.2 Increased number of Merger and Acquisition
5.3.2.3 Increased adoption of DNA probe-based diagnostics
5.3.3 Restraints
5.3.3.1 Stringent regulatory approvals
5.3.3.2 Lack of skilled labor
5.3.4 DRO - Impact Analysis
5.3.5 Key Stakeholders
6 Market Segmentation by Technology: Market Size and Analysis
6.1 Overview
6.2 Polymerase Chain Reaction (PCR)
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4 Microarray
6.5 Hybridization
6.6 DNA Sequencing
6.7 Other MDX technology
7 Market Segmentation by Application: Market Size and Analysis
7.1 Overview
7.2 Oncology
7.3 Blood Testing
7.4 Infectious Diseases
7.5 Genetic Testing
7.6 Tissue Typing
7.7 Others
8 End-user: Market Size and Analysis
8.1 Overview
8.2 Hospitals
8.3 Reference Laboratories
8.4 Others
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.2.1 US 40
9.3 Europe
9.3.1 UK 41
9.3.2 Germany
9.4 APAC
9.4.1 India
9.4.2 China
9.4.3 Japan
9.5 Rest of the World
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Africa
10 Competitive Landscape
10.1 Overview
11 Vendor Profiles
11.1 F.Hoffmann-La Roche Ltd
11.1.1 Overview
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Abbott Laboratories
11.2.1 Overview
11.2.2 Business Unit
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategy
11.3 Siemens Healthineers Inc.
11.3.1 Overview
11.3.2 Geographic Presence
11.3.3 Business Focus
11.3.4 SWOT Analysis
11.3.5 Business Strategy
11.4 Danaher Corporation.
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Hologic Inc.
11.5.1 Overview
11.5.2 Business Unit
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategy
12 Companies to Watch For
12.1 Becton Dickinson and Company
12.1.1 Overview
12.2 Bio-Rad Laboratories' Inc.
12.2.1 Overview
12.3 QIAGEN NV
12.3.1 Overview
12.4 bioMerieux S.A.
12.4.1 Overview
12.5 ThermoFisher Scientific.
12.5.1 Overview
Annexure
12.6 Abbreviations